Ann: ASX Confirms G Medical Delisting, page-20

https://themarketherald.com.au/g-medical-innovations-asxgmv-to-de-list-from-asx-2020-08-14/

Within that time will be a short period of privatization, which the company hopes will allow them to bring onboard some U.S. investors at an improved per-share price point.

The company believes the share price will bounce on the Nasdaq, as it has received advice from the U.S. that the Nasdaq has a greater understanding and appreciation for medical technology companies.

G Medical CEO Dr Yacov Geva said the proposed listing on the Nasdaq presented the company an opportunity that will “lead to a comprehensive re-rating of the company.”

“It gives shareholders exposure to a very well respected and regulated exchange where telehealth and medical technology is much better understood," Yacov explained.